3/1付でEMAから「動物に使用される抗生物質のヒト・動物への影響に関する Reflection paper」が発出されています。
動物のみならずヒトへの耐性リスクも考慮した内容です。
関係者及び興味のある方は、下記URLsのReflection paper並びにパブコメ時のご意見等をご参照ください。
【ヒト・動物への影響】
l3/1付New「Reflection paper on the use of aminopenicillins and their beta-lactamase inhibitor combinations in animals in the European Union: development of resistance and impact on human and animal health - First version」
https://www.ema.europa.eu/en/documents/scientific-guideline/reflection-paper-use-aminopenicillins-their-beta-lactamase-inhibitor-combinations-animals-european_en.pdf
l3/1付パブコメご意見「Overview of comments received on 'Reflection paper on the use of aminopenicillins and their beta-lactamase inhibitor combinations in animals in the European Union: development of resistance and impact on human and animal health - First version'」
https://www.ema.europa.eu/en/documents/comments/overview-comments-received-reflection-paper-use-aminopenicillins-their-beta-lactamase-inhibitor_en.pdf
l3/1付Updated「Use of aminopenicillins and their beta-lactamase inhibitor combinations in animals in the European Union: development of resistance and impact on human and animal health」
https://www.ema.europa.eu/en/use-aminopenicillins-their-beta-lactamase-inhibitor-combinations-animals-european-union-development
【動物用医薬品としての影響】
l3/1付New「Reflection paper on antimicrobial resistance in the environment: considerations for current and future risk assessment of veterinary medicinal products - First version」
https://www.ema.europa.eu/en/documents/scientific-guideline/reflection-paper-antimicrobial-resistance-environment-considerations-current-future-risk-assessment_en.pdf
l3/1付パブコメご意見「Overview of comments received on the 'Reflection paper on antimicrobial resistance in the environment: considerations for current and future risk assessment of veterinary medicinal products - First version'」
https://www.ema.europa.eu/en/documents/comments/overview-comments-received-reflection-paper-antimicrobial-resistance-environment-considerations_en.pdf
l3/1付Updated「Antimicrobial resistance in the environment: considerations for current and future risk assessment of veterinary medicinal products」
https://www.ema.europa.eu/en/antimicrobial-resistance-environment-considerations-current-future-risk-assessment-veterinary
動物のみならずヒトへの耐性リスクも考慮した内容です。
関係者及び興味のある方は、下記URLsのReflection paper並びにパブコメ時のご意見等をご参照ください。
【ヒト・動物への影響】
l3/1付New「Reflection paper on the use of aminopenicillins and their beta-lactamase inhibitor combinations in animals in the European Union: development of resistance and impact on human and animal health - First version」
https://www.ema.europa.eu/en/
l3/1付パブコメご意見「Overview of comments received on 'Reflection paper on the use of aminopenicillins and their beta-lactamase inhibitor combinations in animals in the European Union: development of resistance and impact on human and animal health - First version'」
https://www.ema.europa.eu/en/
l3/1付Updated「Use of aminopenicillins and their beta-lactamase inhibitor combinations in animals in the European Union: development of resistance and impact on human and animal health」
https://www.ema.europa.eu/en/
【動物用医薬品としての影響】
l3/1付New「Reflection paper on antimicrobial resistance in the environment: considerations for current and future risk assessment of veterinary medicinal products - First version」
https://www.ema.europa.eu/en/
l3/1付パブコメご意見「Overview of comments received on the 'Reflection paper on antimicrobial resistance in the environment: considerations for current and future risk assessment of veterinary medicinal products - First version'」
https://www.ema.europa.eu/en/
l3/1付Updated「Antimicrobial resistance in the environment: considerations for current and future risk assessment of veterinary medicinal products」
https://www.ema.europa.eu/en/
執筆者について
経歴 ※このプロフィールは掲載記事執筆時点での内容となります
コメント
/
/
/
コメント